Esika Colorfix Polvos 32h Polvo Compacto Facial De Alta Cobertura Fps 15 200-c Powder
Product Images NDC 14141-594

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esika Colorfix Polvos 32h Polvo Compacto Facial De Alta Cobertura Fps 15 200-c (NDC 14141-594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bel Star S.a., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

110c (110 C)

110c (110 C)
A drug facts panel in Spanish for Esika Colorfix Polvos 32H, a high coverage compact facial powder with SPF 15. It lists active ingredients Octinoxate 3%, Titanium Dioxide 6.24%, Zinc Oxide 4.90%, all as sunscreen agents. The panel includes usage instructions, warnings about skin cancer risk, directions for application, and a list of inactive ingredients. The product net weight is 0.35 oz (10 g).*
FDA Label Image

180f (180 F)

180f (180 F)
This image shows a Spanish-language drug information panel for ESIKA COLORFIX POLVOS 32H Polvo Compacto Facial de Alta Cobertura FPS 15. It lists the active ingredients Octinoxate 3%, Titanium Dioxide 6.24%, and Zinc Oxide 4.90% as sunscreens, along with warnings, usage instructions, and inactive ingredients. The net weight is 0.35 oz (10 g), and the product is distributed by Ventura Corp., San Juan, Puerto Rico, and made in Colombia.*
FDA Label Image

200c (200 C)

200c (200 C)
Packaging label for ESIKA COLORFIX POLVOS 32H powder compact facial with high coverage and SPF 15 by BEL STAR S.A. The label lists active ingredients: Octinoxate 3%, Titanium Dioxide 6.24%, and Zinc Oxide 4.90%, all serving as sunscreen agents. The net weight is 0.35 oz (10 g). The label includes drug information, warnings, usage instructions, inactive ingredients, and origin details in Spanish.*
FDA Label Image

220c (220 C)

220c (220 C)
Drug facts panel in Spanish for ESIKA COLORFIX POLVOS 32H powder compact facial with high coverage and SPF 15. Lists active ingredients octinoxate 3%, titanium dioxide 6.24%, and zinc oxide 4.9%, all serving as sun protectors. Usage instructions, warnings, and inactive ingredients are detailed. The net weight is 0.35 oz (10 g).*
FDA Label Image

270c (270 C)

270c (270 C)
Drug facts panel in Spanish for ESIKA COLORFIX POLVOS 32H, a compact facial powder with high coverage and SPF 15. The panel lists active ingredients Octinoxate 3%, Titanium Dioxide 6.24%, and Zinc Oxide 4.90% as sunscreen agents. It includes usage instructions, warnings about skin cancer and premature aging risk, application directions, inactive ingredients, and storage advice. Made in Colombia and distributed in Puerto Rico.*
FDA Label Image

310c (310 C)

310c (310 C)
Drug facts panel in Spanish from ESIKA COLORFIX POLVOS 32H POLVO COMPACTO FACIAL DE ALTA COBERTURA FPS 15 showing active ingredients octinoxate 3%, titanium dioxide 6.24%, and zinc oxide 4.90% as sunscreen agents. Includes usage instructions, warnings, inactive ingredients list, and storage information. Net weight indicated as 0.35 oz. / 10 g.*
FDA Label Image

420c (420 C)

420c (420 C)
Packaging label for Esika Colorfix 32H Polvo Compacto Facial de Alta Cobertura FPS 15 powder, a topical human OTC drug. The label shows active ingredients Octinoxate 3%, Titanium Dioxide 6.24%, and Zinc Oxide 4.90%. It includes instructions, warnings, and inactive ingredients in Spanish. The net weight is 10 g (0.35 oz). The labeler is BEL STAR S.A.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.